# Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients

> **NCT06747130** · PHASE2,PHASE3 · RECRUITING · sponsor: **Phramongkutklao College of Medicine and Hospital** · enrollment: 82 (estimated)

## Conditions studied

- Dengue
- Montelukast
- Transaminases

## Interventions

- **DRUG:** Montelukast
- **DRUG:** Montelukast Placebo

## Key facts

- **NCT ID:** NCT06747130
- **Lead sponsor:** Phramongkutklao College of Medicine and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-31
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06747130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06747130, "Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06747130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*